Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients

Abstract

Even in the late era of highly effective antiretroviral treatments, detection of CWR, particularly if extended to all three drug classes is related to poorer clinical outcome and represents a risk-marker of disease progression and death.